Stiripentol

Last Updated: 09/19/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 442 publications

Integrated Radioproteomic Modeling for Early Recurrence Prediction and Metabolic Characterization in Hepatocellular Carcinoma.

Integrated Radioproteomic Modeling for Early Recurrence Prediction and Metabolic Characterization in Hepatocellular Carcinoma.

Journal: JCO precision oncology
Published: July 29, 2026

Impact of novel anti-seizure medications on status epilepticus in Dravet syndrome: a multicenter real-world cohort study.

Impact of novel anti-seizure medications on status epilepticus in Dravet syndrome: a multicenter real-world cohort study.

Journal: Seizure
Published: June 17, 2026

Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics.

Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics.

Journal: Epilepsia open
Published: June 08, 2026

Protein Adduction and Hepatotoxicity Induced by Stiripentol.

Protein Adduction and Hepatotoxicity Induced by Stiripentol.

Journal: Chemical research in toxicology
Published: April 28, 2026

Bridging evidence gaps in dravet syndrome: real-world safety insights from under-reported antiseizure therapies.

Bridging evidence gaps in dravet syndrome: real-world safety insights from under-reported antiseizure therapies.

Journal: Expert opinion on drug safety
Published: April 25, 2026

Early-Onset and Syndromic Pediatric Epilepsy in Kazakhstan: Clinical, Molecular, and Phenotypic Spectrum.

Early-Onset and Syndromic Pediatric Epilepsy in Kazakhstan: Clinical, Molecular, and Phenotypic Spectrum.

Journal: Journal of clinical medicine
Published: April 17, 2026

Acute effects of anti-seizure medications on network level dynamics: A systematic comparison using multielectrode arrays.

Acute effects of anti-seizure medications on network level dynamics: A systematic comparison using multielectrode arrays.

Journal: Epilepsia
Published: April 14, 2026

Pharmacokinetics, Safety, and Dosing of Antiseizure Medications in Patients with Renal or Hepatic Impairment.

Pharmacokinetics, Safety, and Dosing of Antiseizure Medications in Patients with Renal or Hepatic Impairment.

Journal: Clinical pharmacokinetics
Published: March 24, 2026

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

Journal: Epilepsia
Published: March 13, 2026

Lipid Nanoparticles with Stiripentol and Cannabidiol Oil: From Rational Optimization to Preclinical Characterization.

Lipid Nanoparticles with Stiripentol and Cannabidiol Oil: From Rational Optimization to Preclinical Characterization.

Journal: Pharmaceutics
Published: March 07, 2026

Optimizing polytherapy management for Dravet syndrome in the United States: A National Expert Consensus.

Optimizing polytherapy management for Dravet syndrome in the United States: A National Expert Consensus.

Journal: Epilepsia open
Published: March 06, 2026

Exploring the caregiver journey through randomized controlled trials in dravet syndrome: insights from a cross-sectional survey.

Exploring the caregiver journey through randomized controlled trials in dravet syndrome: insights from a cross-sectional survey.

Journal: Epilepsy & behavior : E&B
Published: March 06, 2026
Showing 1-12 of 442

Last Updated: 09/19/2026